National Institute on Drug Abuse (NIDA) clinical trials
Listed in the registry as: U.S. National Institutes of Health.
The registry lists 393 studies whose lead sponsor is National Institute on Drug Abuse (NIDA). 19 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the National Institute on Drug Abuse (NIDA) studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- United States
- 374
Focus areas
Conditions National Institute on Drug Abuse (NIDA) leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 393. Browse all 393 →
- Spironolactone in Alcohol Use Disorder (SAUD)RecruitingNCT05807139Phase 1
- SMART-r: Substance Monitoring and Active Relapse Tracking RepositoryRecruitingNCT06676059
- Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)Not yet recruitingNCT06868914Phase 1
- Environment and Alcohol: A Pilot StudyRecruitingNCT06860607Phase 1
- Developing Transcranial Neuromodulation Protocols for Learning and Decision-MakingRecruitingNCT06561828Early Phase 1
- Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of FentanylEnrolling by invitationNCT06995885
- Olfactory Function and Model-Based Behavior in People Living With HIV and SUDRecruitingNCT07637669
- Causal Mechanisms of Odor-Guided Behavior in HumansNot yet recruitingNCT07099092Early Phase 1
- Outcome Inference in the Sensory Preconditioning Task in Opioid-Use DisorderRecruitingNCT03745339
- Advanced Functional and Structural MRI Techniques for Neuropharmacological ImagingRecruitingNCT01036581Not applicable
- Mechanism of Non-invasive Magnetic StimulationRecruitingNCT03394066Not applicable
- Development and Validation of Learning and Decision-Making TasksRecruitingNCT05707806
- Trial of Tirzepatide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07468552Phase 2
- Defining Neurobiological Links Between Substance Use and Mental IllnessRecruitingNCT05538910Not applicable
- Orexin s Role in the Neurobiology of Substance Use DisorderRecruitingNCT05630781Not applicable
- Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRPRecruitingNCT06552741
- Phase 1 Study of Oral MG001Not yet recruitingNCT07204171Phase 1
- VK4-116 Phase I Study With Food-EffectNot yet recruitingNCT06808932Phase 1
- Evaluation of the Interactions of Cannabidiol (CBD) With MorphineRecruitingNCT05143424Phase 1
- Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use DisorderSuspendedNCT06577454Not applicable
- Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment PopulationCompletedNCT00787423
- Characterization of Phenotypic and Genotypic Regressors for ImagingCompletedNCT01148381
- Cognitive Task Development and Implementation for Functional MRI StudiesCompletedNCT01036685
- Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverityCompletedNCT01867411
- Health Outcomes by Neighborhood - BaltimoreCompletedNCT01571752
- Semaglutide Therapy for Alcohol Reduction (STAR)Active, not recruitingNCT06015893Phase 2
- Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot StudyCompletedNCT03152760
- Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use DisorderActive, not recruitingNCT06233799Phase 3
- Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUDTerminatedNCT04316559Phase 2
- SXC-2023 Cocaine Interaction StudyCompletedNCT06343532Phase 1
- Screening Protocol for the Evaluation of Potential Research SubjectsCompletedNCT01036971
- Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot StudyTerminatedNCT06503159Not applicable
- Adolescent Vaping Characterization and Parent Views on Adolescent Vaping ProtocolTerminatedNCT05669716
- Just-In-Time Adaptive Interventions for Addictive BehaviorsTerminatedNCT03538652Not applicable
- Real-world Momentary Assessment of Kratom Use Accompanied by Product Assays: A Natural-history Study for Interdisciplinary Characterization of Kratom Use and PharmacologyCompletedNCT05457803
- Theta-Burst Stimulation as a Treatment for Reducing Cocaine UseTerminatedNCT02927236Not applicable
- Effects of a New Behavioral Intervention on Alcohol Craving and DrinkingCompletedNCT02831049Not applicable
- Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use DisorderCompletedNCT03896516Phase 1/2
- Nicotine Withdrawal Symptoms and Smoking RelapseCompletedNCT01511614Not applicable
- Imaging Biomarker for Addiction Treatment OutcomeTerminatedNCT03427424
- Three Strategies for Implementing Motivational Interviewing on Medical Inpatient UnitsCompletedNCT01825057Not applicable
- Evaluation of Intranasal Naltrexone and NaloxoneCompletedNCT03851731Phase 1
- Lorcaserin in the Treatment of Cocaine Use DisorderCompletedNCT03007394Phase 2
- State and Trait Mediated Response to TMS in Substance Use DisorderWithdrawnNCT03707600Not applicable
- Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot StudyCompletedNCT02231892Not applicable
- Reward Processing in Cocaine AddictionCompletedNCT01036074
- Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency ManagementCompletedNCT00292110Phase 1
- Stem Cell Study of Genetics and Drug AddictionCompletedNCT01534624
- Clonidine for Relapse Prevention in Buprenorphine-Maintenance PatientsCompletedNCT00295308Phase 1
- Factors Affecting Methamphetamine and Opiates Drug TestingCompletedNCT01736332Phase 1